Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aortic Aneurysm | 3 | 2015 | 649 | 0.160 |
Why?
|
| Aorta | 3 | 2018 | 2045 | 0.160 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2018 | 577 | 0.110 |
Why?
|
| Marfan Syndrome | 1 | 2015 | 237 | 0.100 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2018 | 843 | 0.100 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2018 | 707 | 0.100 |
Why?
|
| Efficiency, Organizational | 1 | 2016 | 697 | 0.100 |
Why?
|
| Systemic Vasculitis | 1 | 2012 | 37 | 0.100 |
Why?
|
| Nitrogen Radioisotopes | 1 | 2009 | 44 | 0.080 |
Why?
|
| Turner Syndrome | 1 | 2010 | 130 | 0.080 |
Why?
|
| Aortitis | 1 | 2009 | 77 | 0.080 |
Why?
|
| Aortic Rupture | 1 | 2012 | 322 | 0.080 |
Why?
|
| Ammonia | 1 | 2009 | 247 | 0.080 |
Why?
|
| Giant Cell Arteritis | 1 | 2012 | 307 | 0.070 |
Why?
|
| Immune System Diseases | 1 | 2009 | 253 | 0.070 |
Why?
|
| Moyamoya Disease | 1 | 2010 | 274 | 0.070 |
Why?
|
| Vasodilator Agents | 1 | 2009 | 990 | 0.060 |
Why?
|
| Adenosine | 1 | 2009 | 820 | 0.060 |
Why?
|
| Coronary Stenosis | 1 | 2009 | 802 | 0.050 |
Why?
|
| Coronary Circulation | 1 | 2009 | 1617 | 0.050 |
Why?
|
| Myocardial Infarction | 3 | 2008 | 11519 | 0.050 |
Why?
|
| Sodium | 1 | 2008 | 1597 | 0.050 |
Why?
|
| Decision Making | 1 | 2016 | 3953 | 0.050 |
Why?
|
| Biomedical Research | 1 | 2016 | 3463 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2016 | 8080 | 0.050 |
Why?
|
| Radiopharmaceuticals | 1 | 2009 | 2735 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2016 | 5367 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2008 | 3780 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2009 | 4568 | 0.040 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2008 | 2145 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2008 | 36743 | 0.030 |
Why?
|
| Gadolinium DTPA | 2 | 2008 | 823 | 0.030 |
Why?
|
| Heart Failure | 1 | 2018 | 11879 | 0.030 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2016 | 312 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2009 | 6669 | 0.030 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2018 | 1096 | 0.030 |
Why?
|
| Serine Endopeptidases | 1 | 1997 | 1027 | 0.020 |
Why?
|
| Diffusion of Innovation | 1 | 2016 | 724 | 0.020 |
Why?
|
| Glucocorticoids | 2 | 2012 | 2167 | 0.020 |
Why?
|
| Point Mutation | 1 | 1995 | 1596 | 0.020 |
Why?
|
| Sodium Isotopes | 1 | 2008 | 11 | 0.020 |
Why?
|
| Aorta, Abdominal | 1 | 2012 | 627 | 0.020 |
Why?
|
| Receptors, Androgen | 1 | 1995 | 1089 | 0.020 |
Why?
|
| Aortic Valve | 1 | 2018 | 1970 | 0.020 |
Why?
|
| Fuzzy Logic | 1 | 2008 | 58 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 1997 | 3711 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 2018 | 3841 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 1997 | 3044 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1997 | 4352 | 0.020 |
Why?
|
| Aorta, Thoracic | 1 | 2012 | 1110 | 0.020 |
Why?
|
| Contrast Media | 2 | 2008 | 5330 | 0.010 |
Why?
|
| Prednisone | 1 | 2009 | 1567 | 0.010 |
Why?
|
| Computer Simulation | 2 | 2008 | 6283 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2008 | 2300 | 0.010 |
Why?
|
| Recurrence | 1 | 2015 | 8509 | 0.010 |
Why?
|
| Massachusetts | 1 | 2015 | 8890 | 0.010 |
Why?
|
| Middle Aged | 5 | 2018 | 223492 | 0.010 |
Why?
|
| Humans | 12 | 2018 | 768166 | 0.010 |
Why?
|
| ROC Curve | 1 | 2009 | 3628 | 0.010 |
Why?
|
| Male | 7 | 2018 | 364719 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 1997 | 10266 | 0.010 |
Why?
|
| Phantoms, Imaging | 1 | 2008 | 2512 | 0.010 |
Why?
|
| Electronic Health Records | 1 | 2016 | 4887 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2016 | 5520 | 0.010 |
Why?
|
| Aged | 4 | 2015 | 171504 | 0.010 |
Why?
|
| Age Factors | 1 | 2015 | 18412 | 0.010 |
Why?
|
| Echocardiography | 1 | 2010 | 5047 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2009 | 4541 | 0.010 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 1997 | 130 | 0.010 |
Why?
|
| Perforin | 1 | 1997 | 167 | 0.010 |
Why?
|
| Fas Ligand Protein | 1 | 1997 | 216 | 0.010 |
Why?
|
| Risk Factors | 2 | 2015 | 74944 | 0.010 |
Why?
|
| Granzymes | 1 | 1997 | 277 | 0.010 |
Why?
|
| Female | 5 | 2015 | 397192 | 0.010 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2008 | 3390 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2015 | 81762 | 0.010 |
Why?
|
| Immunity, Mucosal | 1 | 1997 | 498 | 0.010 |
Why?
|
| Bone Marrow Diseases | 1 | 1995 | 234 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 14729 | 0.010 |
Why?
|
| Adult | 3 | 2015 | 223646 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 1995 | 11101 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1995 | 1989 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2008 | 9015 | 0.010 |
Why?
|
| Immunity, Cellular | 1 | 1997 | 1561 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 20227 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 1995 | 1744 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 2009 | 6568 | 0.010 |
Why?
|
| Estradiol | 1 | 1995 | 1951 | 0.000 |
Why?
|
| Tumor Cells, Cultured | 1 | 1995 | 6124 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2012 | 65371 | 0.000 |
Why?
|
| Neoplasm Metastasis | 1 | 1995 | 4912 | 0.000 |
Why?
|
| Testosterone | 1 | 1995 | 2491 | 0.000 |
Why?
|
| Base Sequence | 1 | 1995 | 12421 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1997 | 11095 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 59629 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1995 | 17622 | 0.000 |
Why?
|
| Transcription, Genetic | 1 | 1995 | 7608 | 0.000 |
Why?
|
Concepts
(97)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(18)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_